| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/08/2008 | CA2668384A1 A pharmaceutical composition having antipsychotic, antidepressant or antiepileptic activity with reduced side effect |
| 05/08/2008 | CA2668382A1 Reduction of overweight or obesity |
| 05/08/2008 | CA2668363A1 A method of administering an antitumor compound |
| 05/08/2008 | CA2668338A1 Ikk-.beta. serine-threonine protein kinase inhibitors |
| 05/08/2008 | CA2668321A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain |
| 05/08/2008 | CA2668317A1 Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction |
| 05/08/2008 | CA2668316A1 Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction |
| 05/08/2008 | CA2668267A1 Elvucitabine pharmaceutical compositions |
| 05/08/2008 | CA2668255A1 Anilinopiperazine derivatives and methods of use thereof |
| 05/08/2008 | CA2668210A1 Anilinopiperazine derivatives and methods of use thereof |
| 05/08/2008 | CA2668209A1 Anilinopiperazine derivatives and methods of use thereof |
| 05/08/2008 | CA2668182A1 Triazolopyrimidine derivatives as adp p2y12 receptor antagonists |
| 05/08/2008 | CA2668180A1 Triazolopyrimidine derivatives as adp p2y12 receptor antagonists |
| 05/08/2008 | CA2668094A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid and having improved pharmacological properties |
| 05/08/2008 | CA2668070A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | CA2668065A1 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/08/2008 | CA2668027A1 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 05/08/2008 | CA2668020A1 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 05/08/2008 | CA2668010A1 Organo-arsenoxide compounds and use thereof |
| 05/08/2008 | CA2668008A1 Prevention and reversal of chemotherapy-induced peripheral neuropathy |
| 05/08/2008 | CA2668006A1 Substituted pyridin-3-yl amides as 1.beta.hsd1 inhibitors |
| 05/08/2008 | CA2667983A1 Dmae as sole agent for the treatment of mild cognitive impairment |
| 05/08/2008 | CA2667971A1 Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression |
| 05/08/2008 | CA2667970A1 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
| 05/08/2008 | CA2667963A1 3-aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 05/08/2008 | CA2667962A1 Heterocyclic compounds as antiinflammatory agents |
| 05/08/2008 | CA2667960A1 Imidazopyridazines as pi3k lipid kinase inhibitors |
| 05/08/2008 | CA2667949A1 Methods for treating depression |
| 05/08/2008 | CA2667927A1 3-amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases |
| 05/08/2008 | CA2667924A1 The use of pramipexole or a salt thereof for the treatment of parkinson's disease |
| 05/08/2008 | CA2667909A1 Treatment of pervasive developmental disorders |
| 05/08/2008 | CA2667864A1 Formulations of phospholipase enzyme inhibitors |
| 05/08/2008 | CA2667857A1 8-sulfonyl-1, 3, 4, 8-tetrahydr0-2h- [1, 4] oxazepino [6, 7-e] indole derivatives and their use as 5-ht6 receptor ligands |
| 05/08/2008 | CA2667856A1 Use of nutritional compositions for preventing disorders |
| 05/08/2008 | CA2667839A1 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/08/2008 | CA2667826A1 Inhibitors of histone deacetylase |
| 05/08/2008 | CA2667685A1 Indazole derivatives useful as l-cpt1 inhibitors |
| 05/08/2008 | CA2667667A1 Solid or aqueous alkaline preparation comprising a creatine component, process for the production thereof and the use thereof |
| 05/08/2008 | CA2667515A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
| 05/08/2008 | CA2667513A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
| 05/08/2008 | CA2667511A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 05/08/2008 | CA2667395A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, their derivatives and their use and processes for their preparation |
| 05/08/2008 | CA2667251A1 Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases |
| 05/08/2008 | CA2667249A1 Antidiabetic bicyclic compounds |
| 05/08/2008 | CA2667211A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar) |
| 05/08/2008 | CA2666534A1 W/o/w emulsion composition |
| 05/08/2008 | CA2666316A1 Pai-1 binding modulators for the treatment of ocular disorders |
| 05/08/2008 | CA2666138A1 Kinase inhibitors |
| 05/08/2008 | CA2664893A1 Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors |
| 05/08/2008 | CA2664430A1 Immunochemically equivalent hiv drug analogs |
| 05/08/2008 | CA2653320A1 Method of inhibiting the transmission of viruses |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918376A1 FGFR4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 05/07/2008 | EP1918304A1 Monoclonal antibodies against the human anti-müllerian hormone type II receptor (AMHR-II) |
| 05/07/2008 | EP1918292A1 Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/07/2008 | EP1918291A1 3-Aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 05/07/2008 | EP1918290A1 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide |
| 05/07/2008 | EP1918289A2 Crystalline fluoroquinolone arginine salt form |
| 05/07/2008 | EP1918287A2 LPA receptor agonists and antagonists and methods of use |
| 05/07/2008 | EP1918286A1 Thiazolhydrazides for treatment of neurodegenerative diseases |
| 05/07/2008 | EP1918285A1 Diazepane-acetamide derivatives as selective 11beta-HSD1 inhibitors |
| 05/07/2008 | EP1918284A1 Hydrazinopyrimidines as cysteine protease inhibitors |
| 05/07/2008 | EP1918281A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1918277A2 Azulene compounds |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1918000A2 Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
| 05/07/2008 | EP1917979A1 Therapeutic agent for atrial fibrillation |
| 05/07/2008 | EP1917978A1 Premature ovulation preventive agent |
| 05/07/2008 | EP1917973A1 Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof |
| 05/07/2008 | EP1917966A1 Agents and methods for protection treatment and repair of connective tissue |
| 05/07/2008 | EP1917965A1 Inhibitors of the mutant form of KIT |
| 05/07/2008 | EP1917964A1 Percutaneously absorbable ophthalmic preparation |
| 05/07/2008 | EP1917963A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents |
| 05/07/2008 | EP1917962A1 Pharmaceutical composition for modified release insulin sensitiser |
| 05/07/2008 | EP1917961A1 Capsinoid containing composition |
| 05/07/2008 | EP1917960A1 Improved biological effects of rosmarinic acid |
| 05/07/2008 | EP1917959A1 New medical use of alfa-ketoglutarate |
| 05/07/2008 | EP1917958A2 Improved HIV protease inhibitors pharmaceutical formulations |
| 05/07/2008 | EP1917956A2 External preparation composition |
| 05/07/2008 | EP1917955A2 Performance enhanced cosmetic agent with purine and/or purine derivatives II |
| 05/07/2008 | EP1917863A1 Fatty oil made from perilla seeds with improved characteristics |
| 05/07/2008 | EP1917350A2 A biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart |
| 05/07/2008 | EP1917267A1 Crystal form of asenapine maleate |
| 05/07/2008 | EP1917265A1 HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF |
| 05/07/2008 | EP1917264A1 Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/07/2008 | EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 05/07/2008 | EP1917261A1 Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine d3 receptor modulators |
| 05/07/2008 | EP1917260A2 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method |
| 05/07/2008 | EP1917259A2 Pyrazine kinase inhibitors |
| 05/07/2008 | EP1917258A2 Pyrimidinyl-pyrazole inhibitors of aurora kinases |
| 05/07/2008 | EP1917257A1 Substituted triazole derivatives as oxytocin antagonists |
| 05/07/2008 | EP1917256A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 05/07/2008 | EP1917252A1 Pyrazine derivatives and use as pi3k inhibitors |
| 05/07/2008 | EP1917251A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 05/07/2008 | EP1917249A1 3-oxo-indazole-squaric acid derivatives |
| 05/07/2008 | EP1917248A1 1-acyldihydropyrazol derivatives |
| 05/07/2008 | EP1917247A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |